SYNAREL 200 MCG
NAFARELIN (NAFARELIN ACETATE) : 200 MCG · DIN 02188783 · PFIZER CANADA ULC
Health Canada status: MARKETED
What is SYNAREL?
SYNAREL 200 MCG contains NAFARELIN (NAFARELIN ACETATE) : 200 MCG. It is listed in the Health Canada Drug Product Database under DIN 02188783, held by PFIZER CANADA ULC, supplied as METERED-DOSE AEROSOL for NASAL administration. Health Canada currently lists it as marketed, status dated 09-Oct-2003. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is SYNAREL used for?
Synarel (nafarelin acetate) is indicated for hormonal management of endometriosis, including pain relief and reduction of endometriotic lesions. Experience with Synarel for the management of endometriosis has been limited to women 18 years of age and older and treated for 6 months. There is no evidence that pregnancy rates are enhanced or adversely affected by the use of Synarel.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02188783 |
|---|---|
| Brand name | SYNAREL |
| Generic / active ingredient | NAFARELIN (NAFARELIN ACETATE) : 200 MCG |
| Manufacturer | PFIZER CANADA ULC |
| Strength | 200 MCG |
| Dosage form | METERED-DOSE AEROSOL |
| Route of administration | NASAL |
| Schedule | Prescription |
| ATC code | H01CA02 NAFARELIN |
| AHFS class | 68:18.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 09-Oct-2003 |
| Original market date | 1996-11-25 00:00:00 |
How is it stored and handled?
null
How is it supplied?
null
What can be used instead?
Other Canadian products sharing ATC code H01CA02 NAFARELIN. 1 of 2 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| SYNAREL NAS SOL 2MG/ML | 2 MG | LIQUID | SYNTEX INC. | CANCELLED POST MARKET | DIN 01908421 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.